Sangamo Therapeutics, Inc 10-K for FY2019
Sangamo Therapeutics, Inc (SGMOQ)
10-K
2020-02-28
For: 2019-12-31
View Original
Added on
April 10, 2026
About this 10-K
Sangamo Therapeutics, Inc filed this 10-K on February 28, 2020, covering the fiscal year ended December 31, 2019 (FY2019).
Headline figures
Fiscal year ended December 31, 2019, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $102.43M
- up 21.3% from $84.45M a year earlier
- Net loss
- $95.19M
- compared with a net loss of $68.33M a year earlier